Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An HIV-1 integrase genotype assay for the detection of drug resistance mutations.

Sexual health - 1 Dec 2009

Hearps Anna C, Greengrass Vicki, Hoy Jennifer, Crowe Suzanne M

Abstract excerpt

BACKGROUND: The integrase inhibitors (e.g. Raltegravir) are a new class of antiretroviral drugs that have recently become available for the treatment of patients with multi-drug resistant HIV-1 within Australia. The emergence of mutations that confer resistance to the integrase inhibitors has been observed in vivo; however, no commercial genotyping assay is currently available to screen for resistance to these...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Australia
Share to Drug Resistance, Multiple, Viral
Share to HIV-1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Integrase

Share to HIV Integrase Inhibitors

Share to Polymerase Chain Reaction

Share to RNA, Viral

Source

Identifiers

PMID: 19917199
DOI: 10.1071/SH09041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An HIV-1 integrase genotype assay for the detection of drug resistance mutations.PMID 19917199Read ↗

Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeqSemantic proximity Read ↗

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited SettingsSemantic proximity Read ↗

HIV-1 genotyping of the protease-reverse transcriptase and integrase genes to detect mutations that confer antiretroviral resistance.Semantic proximity Read ↗

A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1.Semantic proximity Read ↗

Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance.Semantic proximity Read ↗

Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings.Semantic proximity Read ↗

Analysis of transmitted HIV drug resistance from 2005 to 2015 in Victoria, Australia: a comparison of the old and the new.Semantic proximity Read ↗

Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.Semantic proximity Read ↗

Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009-2012.Semantic proximity Read ↗

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.Semantic proximity Read ↗

Evaluation of a HIV-1 drug resistance genotyping method based on high-throughput sequencing (HTS).Semantic proximity Read ↗

A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.